Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of unknown origin. After onset of the first symptoms, the median survival without respiratory assistance is 19 months 1 and about 7 months in patients with documented diaphragmatic involvement 2 . Most deaths are due to respiratory causes 3 . For these reasons, noninvasive ventilation (NIV) is now part of standard care of ALS 4, 5 . By delivering positive pressure ventilatory assistance via a nasal or face mask, NIV relieves dyspnea and improves quality of life 6 . The survival benefit of NIV has been reported to range from 7 months 7 to 12 months or more 8, 9 . Intolerance of NIV or lack of availability of NIV 8, 9 is a missed opportunity to improve quality of life and prognosis 4 .
However, initiation of NIV is more difficult in ALS patients than in patients with other neuromuscular diseases 10 , while the quality of correction of nocturnal hypoventilation has a direct impact on prognosis 11 . The failure of NIV to maintain satisfactory ventilation at night is related to the presence of leaks in more than one half of cases 11 , but other mechanisms, sometimes associated, are also involved, including upper airway obstructive events, central events comprising reduction of the ventilatory drive, and patient-ventilator asynchrony 11, 12 .
When nocturnal hypoventilation persists after correction of leaks, it is recommended to perform respiratory polygraphy during NIV to identify the mechanisms responsible 13 . We describe the role of upper airway obstructive events in failure of NIV in patients with ALS, their clinical characteristics, and their intrinsic prognostic impact.
Material and Methods

Background
This single-center observational study was conducted in the Department of Respiratory Medicine and Medical Intensive Care of a 1600-bed university hospital. This department is associated with the rare diseases reference center for ALS in the same hospital. Initiation and surveillance of NIV in ALS patients is performed in an 8-bed day-care unit, according to a recently validated model 14 , which devotes 80% of its activity to the management of respiratory failure in ALS 11 .
Patients
Between 2011 and 2012, NIV was initiated in our center in 190 patients with definite or probable ALS according to El Escorial criteria 15 , and the patients' outcome was followed until 2014. NIV was well tolerated (NIV > 4 h/24 h) by 179 of these patients 8 (Figure 1 ). All these 179 patients were included in the analysis. Analysis of these data was approved by the Institutional Review Board of the Société de Pneumologie de Langue Française (French learned society for respiratory medicine), and all patients provided their written informed consent to the anonymous use of their personal data. All the patients received riluzole, and, as appropriate, secretions management with In/Exsuffflator and gastrostomy. The patients and their caregivers all received logistical and psychological support by the Paris ALS Network care 16 .
Respiratory management and evaluation
The indication for NIV was based on the current consensual criteria 5 . NIV was initiated according to the current standardized procedure in the department, over a period of 3 to 5 days 17 (Table 1) . During the follow up, the effectiveness of NIV was assessed in terms of symptoms (including NIV-related discomfort), blood gases, the analysis of ventilator-recorded tracings and nocturnal oximetry. This was performed in all patients in a systematic manner after one month of NIV (M1) and then every three months, as previously described in in detail 11 . Patients were considered to be inadequately ventilated (16) at night when they presented nocturnal SpO 2 < 90% for more than 5% of the nocturnal recording time 11 . Built-in monitoring software was used to detect air leaks, which were then corrected. In the absence of leaks 18 , ventilator software were able to detect with good accuracy possible obstructive events (see previously report for details 11 ) ( Figure 2 ) and nap polygraphy (or polysomnography for 5 patients) was then performed in all the patients inadequately ventilated and who were suspected to have upper airway obstructive events ( Figure 2 ) 13 . An obstructive event on NIV was defined by a ≥ 50% drop in airflow for 10 seconds or longer 19 with no concomitant changes in the amplitude of the pressure signal 13 and was considered to be associated with reduction in ventilatory drive 13 when it occurred in the absence of associated thoracoabdominal paradox 19 . The absence of obstructive events was defined by an obstruction index < 5/h on the ventilator software 20 . All the patients were ventilated with a respiratory backup rate, to provide for central apneas 13 . Pharyngolaryngeal assessment was also performed by nasal endoscopy (Pentax, VNL-1190STK), during spontaneous breathing in 11 patients and noninvasive ventilation in 1 patient ( Figure 3 and supplementary video on line).
Interventions in case of inadequate ventilation due to obstructive events
After correction of the leaks, the corrective interventions in patients were, in this order : 1/ step by step increase in expiratory positive airway pressure (EPAP) to a maximum of 10 cmH20 if tolerated; 2/ trial use of self-adapting inspiratory pressure devices (IVAPS mode, Resmed, Sydney, Australia; AutoAdvanced, Philips Respironics, Pensylvania, USA); 3/ switch to volume-controlled mode; 4/ trial of other mechanical treatments (mandibular advancement device, cervical collar).
Statistical analysis
Descriptive statistics used numbers and percentages for qualitative variables and Quantitative variables were described in terms of their median and interquartile range because of strong skewness in some distributions. Comparisons between groups of patients used Chi 2 tests for qualitative variables and Wilcoxon-Mann-Whitney tests for quantitative variables. Prognostic factors were analyzed in the framework of survival analysis. Survival time was defined as the time between first signs of the disease and date of death. Patients alive at the date of analysis were considered to be censored at this date. Survival functions were estimated by the Kaplan-Meier method and between-group comparisons were tested by log-rank tests. All computations were performed by SAS V9.3 (SAS Institute Inc, Cary, NC, USA).
Results
After correction of leaks, 106 of the 179 patients evaluated were considered to be adequately ventilated at night (group 1) and 73 remained inadequately ventilated (group 2) (supplementary Table 2 (Table 1) , except that Group O-comprised more patients with bulbar onset ALS (24 patients versus 12, p = 0.034), but with no significant difference of the bulbar score at the time of initiation of NIV and that GroupO-comprised more patients with gastrostomy (n =21, 23%, vs. n= 9, 10%, in group O +, p = 0.02), without difference in survival in patients with or without gastrostomy in the whole group. In the adequately ventilated patients, the patients with upper airway obstructive events had more desaturations but all less than 5% of the night, and a shorter use of NIV (supplementary Table 3 
on line).
In all O + patients, obstructive events were consistently associated with a reduction of ventilatory drive (Figure 2 ). In the 20 patients in whom complete PSG was performed, obstructive events predominantly occurred during REM sleep, but were always associated with loss of accessory respiratory muscle activity.
None of the patients presented hyperventilation on NIV (Table 1) Other treatments were tried without success: custom-made mandibular advancement device, as also recently described by Veldhuis et al. 21 , was tried in addition to NIV in 4 patients, but was discontinued after 3 to 6 months due to poor tolerance. Due to the possible role of the oronasal mask, the oronasal mask was replaced by a nasal mask, which was not supported by the patients concerned due to air leaks. Anterior dislocation of the jaw using a cervical collar was tried, but without success, in 3 patients.
Discussion
This study confirms that upper airway obstruction is one of the mechanisms of NIV failure in ALS 10, 11, 21, 22 . The prevalence of upper airway obstruction, which has not been previously systematically evaluated, is high (45% of our patients after correction of leaks). It is noteworthy that NIV-related upper airway obstructive events in ALS patients appear to be mediated by central mechanisms, as obstructive events (defined as cessation or marked decrease of flow with maintained airway pressure) are associated with decreased or abolished thoracoabdominal movements ( Figure 2 ). Finally, obstructive events in this setting are associated with poorer prognosis, even when they do not reduce the efficacy of NIV to correct desaturations (group 1 O-patients) (Figure 4 ). Correction of obstructive events improves survival ( Figure 4 ).
Putative mechanisms
Abnormal upper airway collapsibility in ALS
A number of ALS-related factors can theoretically increase upper airway collapsibility. Upper airway involvement has been extensively described in this disease, particularly in the pharynx and larynx 23, 24 , due to degeneration of corticobulbar fibers, with bilateral glossopharyngeal and hypoglossal nerve lesions, responsible for so-called "bulbar" symptoms with impairment of voice and swallowing, atrophy of the tongue with fasciculations and abnormal corticobulbar reflexes 23, 25 . very heterogeneous appearances in endoscopy were observed, ranging from a completely normal airway to complete collapse of the entire airway ( Figure 3 and supplementary video online). However, recent studies in ALS have confirmed that the endoscopic appearance of the pharynx and larynx may be normal despite spontaneous and permanent electromyographic activity of the tongue in a great majority of patients 26 decreased strength of the tongue in almost all patients, even in patients with no dysarthria or swallowing disorders 24 . Decreased strength of the tongue would constitute a predisposing factor to increased upper airway collapsibility and we believe that the prevalence of this abnormality in ALS (with or without an obvious bulbar lesion) is probably severely underestimated. Clinical evaluation (bulbar score) and nasal endoscopy are clearly unable to identify patients at high-risk of upper airway collapse when treated by NIV, indicating the need for a specific diagnostic approach. We did not have enough data to differenciate bulbar and pseudobulbar patients, a differenciation that should be explored in future studies.
Finally, other mechanisms, described in different diseases, may also be responsible of upper airway obstruction; these include chronic irritation of the surface of the pharynx 27 28 , a higher propensity of the airways to collapse at low lung volume 29, 30 or upper airway nocturnal redistribution of interstitial fluid 31 for example.
NIV-related inhibition of compensatory mechanisms
ALS-related obstructive events are observed only during sleep and/or NIV, suggesting the existence of wakefulness-related compensatory mechanisms that have been shown to involve cortical processes. A similar finding has been observed in obstructive sleep apnea syndrome (OSAS), in which snoring and obstructive events are not observed during wakefulness despite the fact that the upper airways of OSAS patients present anatomical and functional abnormalities predisposing to airway collapse. These abnormalities are compensated by increased ventilatory drive to upper airway dilator muscles 32, 33 , in which a specific cortical drive participates 34 . NIV could affect this compensation via several mechanisms. Firstly, NIV may reduce PaCO 2 , which would decrease global ventilatory drive and which could promote glottal closure phenomena in the same way as induction of hypocapnia in healthy subjects 35 .
Secondly NIV could induce mechanical inhibition of ventilatory drive, independent of any variations in CO 2 , and related to changes in thoracic afferents 36 and their cortical processing 37 , as NIV abolishes the cortical activity related to breathing that characterizes some ALS patients, which has been interpreted to be a compensatory mechanism 38 . Finally, a third mechanism could be related to sleep induction, as described in OSAS 39 .
Prognostic impact
In the patients of this series, obstructive events were associated with poorer prognosis, without any obvious confounder for low survival (smoking habits, riluzole use, respiratory secretions management and nutritionnal support). Of note, the presence of a gastrostomy was less often noted in the patients with obstuctive events, probably because of the lower number of bulbar patients in this group (Table 1) . We did not find any difference in survival between patients with or without gastrostomy, as all the patients received nutritional support. We were surprised to find that a poorer survival was observed not only in patients considered to be inadequately ventilated but also in patients considered to be adequately ventilated, i.e. with no nocturnal desaturations (group 1 O + patients). Nocturnal SpO 2 monitoring is therefore
probably not sufficiently precise to detect poor quality sleep in patients with obstructive events or the criteria of nocturnal SpO 2 < 90% for more than 5% of the nocturnal recording time 11 could be to high as suggested in Table 3 . However, this is an important point, as correction of obstructive events is associated with improved survival. The present study shows that adjustments of ventilator settings can control obstructive events in 58% of cases, with no survival difference between patients corrected during treatment and those who were immediately adequately ventilated. The most frequently effective treatment was to try to reduce upper airway collapsibility by increasing EPAP to high levels. Unfortunately, this was not always effective and no therapeutic intervention effective in all patients has yet been identified. Nethertheless, these difference in survival must be analysd with caution in this not controlled, retrospective study and should be confirmed in futur controlled studies.
In conclusion, upper airway obstructive events associated with decreased ventilatory drive and promoted by NIV are observed in more than half of ventilated ALS patients. The presence of this phenomenon must be systematically investigated, as it can be corrected by adjusting ventilator settings in the majority of cases. Although the retrospective and single-center design of this study limits its impact, obstructive events nevertheless appear to be an important phenomenon with an impact on survival. 
